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Mefenamic acid, based on the Biopharmaceutics Classification System (BCS), is a class II 
drug that has high permeability but low water solubility. To improve its intrinsic dissolution rate, it 
is usually combined with a hydrophilic and porous drug carrier like Avicel to create a solid 
dispersion. This study aimed to enhance the intrinsic dissolution rate of mefenamic acid using a 
solid dispersion with Avicel PH-101. The test of intrinsic dissolution rate involved a rotational 
speed of 60 rpm and CO2-free water with a temperature of 37°C as a medium. The interaction of 
mefenamic acid and Avicel PH-101 was analyzed with FTIR and DSC spectroscopy. The test 




) of three replications of 
mefenamic acid, solid dispersion of mefenamic acid and avicel PH-101 (SDMA) with 1:1 ratio, 
SDMA with 1:2 ratio, Physical Mixture of Mefenamic Acid and Avicel PH-101 (PMMA) with 1:1 





















), respectively. The interaction 
between mefenamic acid and Avicel PH-101 created a hydrogen bonding, as evidenced by the shift 
in the peaks of FTIR spectra. Based on the DSC thermogram, the mefenamic acid-Avicel PH-101 
interaction shifted the steep peak on the curve of mefenamic acid slightly. Avicel PH-101 in this 
solid dispersion can increase the intrinsic dissolution rate of mefenamic acid through hydrogen 
bonding instead of decreasing its crystalline structure into an amorphous form.  
. 
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Drug solubility is the major determinant of not only drug formulation and its future 
development but also its therapeutic efficacy (Vemula et al., 2010). Class II drugs in the 
Biopharmaceutics Classification System (BCS) have low solubility but high permeability, and drug 
dissolution controls drug absorption (Krishnaiah, 2010). 
Mefenamic acid is a nonsteroidal anti-inflammatory drug (NSAID) belonging to BCS class 
II drugs (Vikram et al., 2012). It has poor water solubility that ranges from 0.004 mg/mL at 37°C 
(Patil et al., 2010) to 0.2 mg/mL at 25°C (Swathi et al., 2011). However, it is highly soluble in 
hydrophilic organic solvents, such as ethanol (14.8 mg/mL at 25°C) and polyethylene glycol 400 
(11.5 mg/mL at 25°C) (Swathi et al., 2011). Water solubility that determines the dissolution rate of 
mefenamic acid is a primary factor in its bioavailability (Vikram et al., 2012). 
Solid dispersion is one of the promising methods for increasing the solubility and 
dissolution rate of poorly water-soluble drugs. It disperses one or more active ingredients in an 
inert carrier by melting, solvent, or melting-solvent technique (Pamudji et al., 2014). Solid 
dispersions can be created with polymers such as polyvinylpyrrolidone, polyethylene glycol, 
polyvinylpyrrolidone-vinyl acetate copolymers, sodium starch glycolate, Avicel, CAB-O-SIL, and 
crospovidone. Based on the previous in-vivo test, Surface Solid Dispersion (SSD), which employs 
solvent deposition technique, has been proven to increase drug release profile, resulting in 
bioavailability with a rapid onset of action (Khatry et al., 2013).  
Avicel is a hydrophilic filler that tends to expand and absorb water very well (wicking 
mechanism) (Saigal et al., 2009). The mixture of drugs and hydrophilic carriers (i.e., polymers) 
induces high wettability by reducing the surface tension between the drug particles and the 
dissolution medium and, thereby, increasing the interfacial area of contact between them. As a 
result, drug solubility improves (Modi and Tayade, 2006). 
Intrinsic dissolution rate is defined as the rate at which drug particles dissolve under the 
interfacial area that depends on stirring speed and the acidity (pH) and constant ionic strength of 
the dissolution medium. An effective intrinsic dissolution rate is depicted as a mass transfer from a 
solid surface to the liquid phase (Dezani et al., 2013).   
This research aimed to determine the intrinsic dissolution rate of the solid dispersion of 
mefenamic acid and Avicel PH-101 and analyze their interaction.  
. 
  
MATERIALS AND METHOD  
Materials 
The tools used in this study included an analytic balance (EX225D Explorer, Ohaus), UV-
1800 spectrophotometer (Shimadzu), FTIR spectrophotometer (Thermo Scientific Nicolet iS 10), 
DSC-60 Plus, hotplate and stirrer (LMS-1003; Labtech), mixer motor (RW 20; IKA), the Wood’s 
dissolution tool that had been modified by Yuwono, pellet printing device (4350 L; Carver), and 
water bath (Memmert). 
The main materials and ingredients used in this study were mefenamic acid 
(pharmaceutical degree; PT. Brataco, Bekasi), Avicel PH-101 (pharmaceutical degree; PT. Brataco, 
Bekasi), NaOH (analytical degree; PT. Merck Indonesia), ethanol 96% (pharmaceutical degree; PT. 
Brataco, Bekasi), and distilled water. 
 
Methods 
Identification of wavelength of maximum absorbance (λmax) of mefenamic acid 
The wavelength of maximum absorbance (λmax) of mefenamic acid was determined from 
the mefenamic acid solution in 0.1 N NaOH with a concentration of 10 µg/mL (Nerdy, 2017). 
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Generation of the standard curve of mefenamic acid 
The absorbances of mefenamic acid solution in 0.1 N NaOH with different concentrations, 
i.e., 5, 7.5, 10, 12.5, and 15 μg/mL, were measured at the λmax of mefenamic acid and used to 
generate the equation of the standard curve (Nerdy, 2017). 
 
Identification of λmax of mefenamic acid-Avicel PH-101 
The wavelength of maximum absorbance (λmax) of mefenamic acid-Avicel PH-101 was 
determined from the mefenamic acid-Avicel solution (1:1) in 0.1 N NaOH with a concentration of 
10 µg/mL. 
 
Generation of the standard curve of mefenamic acid-Avicel  
The absorbances of mefenamic acid-Avicel solution (1:1) in 0.1 N NaOH with different 
concentrations, i.e., 5, 7.5, 10, 12.5, and 15 μg/mL, were measured at the λmax of mefenamic acid-
Avicel PH-101 and used to generate the equation of the standard curve (Nerdy, 2017). 
 
Preparation of the solid dispersion of mefenamic acid with Avicel PH-101 (SDMA) 
The solid dispersion of mefenamic acid and Avicel PH-101 was made with two ratios using 
the solvent method, i.e., 1:1 and 1:2. Every 500 mg of mefenamic acid was dissolved in 50 mL of 
ethanol 96% and added with Avicel PH-101 while stirred (using a magnetic stirrer). Then, the 
solvent was evaporated in the water bath and dried in an oven at 50°C. The mass produced in this 
process was sieved using a 60 mesh and then stored in a desiccator (Essa and Dwaikat, 2015). 
 
Preparation of the physical mixture of mefenamic acid and Avicel PH-101 (PMMA) 
The physical mixture of mefenamic acid and Avicel PH-101 was weighed with ratios 1:1 and 
1:2, mixed without pressure, and sifted with a 60-mesh sieve.  
 
Pellet preparation 
Pellets in the form of tablets were extruded from 300 mg of mefenamic acid powder, SDMA, 
and PMMA with different ratios. The pellet printing or extrusion used a hydraulic press by 
applying 5 tons of pressure for 5 minutes to the mold.  
 
Test of intrinsic dissolution rate  
The topside of the pellets was poured with melted paraffin, allowing only one surface to 
intersect with the dissolution medium directly. The support, filled with sample, was closed and 
connected to the rotating motor. The dissolution tube was filled with the dissolution medium, 
which was 50 mL of CO2-free distilled water, and the temperature was set with a thermometer at 
37°C. The pellets were attached to the support, then dipped into the dissolution medium and 
arranged in a way that no air bubbles were present underneath. This setting was connected to the 
rotating motor and immediately rotated at a speed of 60 rpm. The dissolution result was sampled 
using a 5 mL pipette every 5 minutes for an hour (i.e., 5, 10, 15, 20, 25, 30, 40, 50, and 60 
minutes). Each of the liquid samples had to be replaced immediately with the dissolution medium 
with the same volume and temperature. The absorbance of each sample was read at the λmax of 
mefenamic acid (Khairinnisa, 2007). 
 
Fourier-transform infrared (FTIR) spectroscopy 
The powder was measured with an infrared spectrophotometer using KBr pellets. The 
absorption spectrum was recorded at wavenumbers between 400-4000 cm
-1
 (Indra and Yulianti, 
2017). The sample powder with KBr was crushed, transferred to the extrusion die, and pressed into 
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a disc in a vacuum condition (Octavia et al., 2015). KBr pellets were prepared by grinding the 
sample with KBr (1% of weight) and pressed by applying 7 tons of pressure for 5 minutes 
(Sammour et al., 2006). 
 
Differential scanning calorimetry (DSC) 
The DSC analyses were performed on mefenamic acid, Avicel PH-101, and the solid 
dispersion of mefenamic acid-Avicel PH-101 (SDMA) with the optimal ratio. Some samples were 
put in the pan and placed on the detector plate. Afterward, they were heated from 25°C to 300°C at 
a rate of 10°C per minute.  
 
Data Analysis 
The intrinsic dissolution rate of mefenamic acid was obtained from the slope of the linear 
curve, which represented the relationship between M/S (the amount of mefenamic acid dissolved 
per unit area) and dissolution time. The effect of the solid dispersion of mefenamic acid-Avicel PH-
101 (SDMA) on intrinsic dissolution rate was determined by statistically comparing the rates of 
mefenamic acid, SDMA with 1:1, 1:2, and 1:5 ratios and PMMA with 1:1 and 1:2 ratios in SPSS.  
 
RESULTS AND DISCUSSION  
Standard curve of mefenamic acid 
The absorbance of 10 µg/mL mefenamic acid solution in 0.1 N NaOH solution was 
measured with UV-Vis spectrophotometer at a wavelength ranging from 200 nm to 400 nm. The 
observation results showed that the wavelength of the maximum absorbance (λmax) of mefenamic 
acid was 284.00 nm; the maximum absorbance was 0.455. The standard curve was generated from 
the absorbances of mefenamic acid with five different concentrations, namely 5, 7.5, 10, 12.5, and 
15 µg/mL. The equation of this standard curve was y = 0.0424x + 0.001 with a correlation value (r-
count) of 1.0000. The r-table for five samples (the number of concentration variation) with df= 3 
and 95% confidence level is 0.878. Because the r-count is higher than r-table, there is a positive 
correlation between concentration and absorbance in this standard curve.  
 
The effect of avicel PH-101 on the λmax of mefenamic acid 
The absorbance of 10 µg/mL mefenamic acid-Avicel PH-101 (1:1) solution in 0.1 N NaOH 
solution was measured with a UV-Vis spectrophotometer at a wavelength of 200-400 nm. The 
observation results showed that the λmax of mefenamic acid was measurable, i.e., 284.80 nm with 
the maximum absorbance of 0.449. This finding explains that Avicel PH-101 shifts the λmax of 
mefenamic acid slightly and affects its absorbance. The standard curve of the solid dispersion of 
mefenamic acid-Avicel PH-101 was used to identify the effects of Avicel PH-101 on the 
absorbance of mefenamic acid. This curve was generated using the same five concentrations as 
mefenamic acid, namely 5, 7.5, 10, 12.5, and 15 µg/mL. The equation of this standard curve was 
y= 0.0388x + 0.071 with a correlation value (r-count) of 0.9949. The r-table for five samples (the 
number of concentration variation) with df= 3 and 95% confidence level is 0.878. Because the r-
count is higher than r-table, there is a positive correlation between concentration and absorbance in 
this standard curve.  
The Shapiro-Wilk normality test revealed that the data were distributed normally. Based on 
the Levene’s test results, the data was distributed homogeneously and, therefore, subjected to 
further parametric paired-samples t-test. This test found that the two standard curves showed a 
significant difference, meaning that the addition of Avicel PH-101 can shift the wavelength and 
increase the absorbance of mefenamic acid considerably. To calculate the amount of dissolved 
mefenamic acid, this research used the linear equation of the standard curve of mefenamic acid-
Avicel PH-101 (1:1), i.e., y = 0.0388x + 0.071. 
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The intrinsic dissolution rate 
The correlation curve of the dissolved mefenamic acid per unit area (M/S) and the 

















Figure 1. The correlation curve between M/S and dissolution time  
 
Table I shows that the samples of SDMA 1:1, SDMA 1:2, PMMA 1:1, and PMMA 1:2 
significantly increase the intrinsic dissolution rate of mefenamic acid, respectively, 4.75, 8.38, 2.5, 
and 5.5 times the rate of pure mefenamic acid. A greater acceleration in the drug’s dissolution rate 
is caused by the mechanism of solid dispersion that can increase the wettability and solubility of 
poorly water-soluble drugs (Babu and Chowdary, 2008). Avicel can enhance the dissolution of 
mefenamic acid with surface solid dispersion using the solvent method (Charumanee et al., 2004). 
 
Table I.  The intrinsic dissolution rates of mefenamic acid, SDMA, and PMMA 
 
































* = significant difference with the intrinsic dissolution rate of mefenamic acid 
 
Interaction of  mefenamic acid and avicel PH-101 based on FTIR-spectroscopic analysis  
The shift and changes in the FTIR spectra profile indicated an interaction between 
mefenamic acid and Avicel PH-101. The interaction is in the form of intermolecular hydrogen 
bonds (Figure 2) because the profile change occurred at a wavelength between 3000-3500 nm. 
Figure 3 shows the wavenumbers that appear in each vibration cluster. The vibration of secondary 
amine groups (N-H stretches) commonly appears between 3100 cm
-1
 and 3500 cm
-1
 (Pavia et al., 
2009). In the FTIR spectra of the mefenamic acid samples, the vibration of the N-H stretches 
appears at a wave number of 3306.55 cm
-1
. Avicel PH-101 does not have a secondary amine group, 
but a peak emerges at a wave number of 3331.63 cm
-1
, indicating hydrogen bonding on O-H 
stretches. The vibration of the O-H stretches that form hydrogen bonds is usually found between 
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3200 and 3570 cm
-1
 (Coates, 2000). The absorbance bands that indicated the vibration of secondary 





, respectively. Both of these bands widened and represented overlapping bands 
between the secondary N-H group of mefenamic acid and the O-H stretches in Avicel PH-101. This 
finding signifies the presence of interaction between mefenamic acid and Avicel PH-101.  
This conclusion is also supported by the ability of mefenamic acid and Avicel PH-101 to 
form hydrogen bonds with other molecules. According to Zaini et al. (2017), the solid dispersion 
system of genistein-PVP K-30 shows the deformation of OH groups in genistein because hydrogen 
bonds are formed between genistein and PVP K-30 polymers. In a solid dispersion system, 




Figure 2. The model of hydrogen bonds that are potentially formed between mefenamic acid 
and Avicel PH-101 (the O atoms in Avicel PH-1010 bonds with the H atoms in the 
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Figure 3. FTIR Spectra of (a) mefenamic acid, (b) Avicel PH-101, (c) PMMA 1:2, 
(d) SDMA 1:2 
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The hydrogen bonds between mefenamic acid and Avicel PH-101 can occur due to the 
dipole-dipole action between the molecules of mefenamic acid and Avicel PH-101. The partially 
positive hydrogen atoms in mefenamic acid are pulled by the electron pairs of O atoms in the 
electronegative Avicel PH-101.  
 
Interaction of  mefenamic acid and avicel PH-101 based on DSC Analysis    
The DSC thermogram of mefenamic acid in Figure 4 shows that its crystalline phase 
surpasses the steep endothermic peak at 232.36°C with ΔH= -72.81 J/g. The amorphous phase of 
Avicel PH-101 exceeds the broad endothermic peak at 104.39°C with ΔH= -90.13 J/g. The DSC 
thermogram of SDMA (1:2) shows that the peaks of mefenamic acid and Avicel PH-101 shift 
slightly, namely 103.34
o
C with ΔH= -77.92 J/g and 231.61
o
C with ΔH= -12,60 J/g. 
This slight shift implies that the heat or temperature needed to melt mefenamic acid in a 
solid dispersion (from crystalline to liquid phase) is smaller than pure mefenamic acid. The 
decrease in enthalpy (ΔH) in the solid dispersion preparation of mefenamic acid-Avicel PH-101 
shows that the amount of heat energy required to break down the crystals of mefenamic acid in 
solid dispersion is smaller than the crystals of pure mefenamic acid. The steep peak of mefenamic 
acid on the DSC thermogram of the solid dispersion of mefenamic acid-Avicel PH-101 indicates 
that this solid dispersion does not change the crystals of mefenamic acid to their amorphous form.  
Based on the FTIR spectra and DSC thermogram analysis of the interaction between 
mefenamic acid and Avicel PH-101, the improved intrinsic dissolution rate of SDMA is caused by 
the presence of intermolecular hydrogen bonds between mefenamic acid drugs and the hydrophilic 
carrier, that is, Avicel PH-101.  
The results of this study indicated SDMA 1:1 and 1:2 can increase the intrinsic dissolution 
rate by 4.75 and 8.38 times compared with the pure mefenamic acid. Considering the addition of 
another component in the tablet formulation, the research found that the optimal ratio for tablet 
formulation was SDMA 1:1.  
                ISSN: 2088 4559; e-ISSN: 2477 0256 












Preparing a solid dispersion of mefenamic acid using the carrier Avicel PH-101 with a ratio 
1:1 can increase the intrinsic dissolution rate of mefenamic acid significantly compared to that of 
pure mefenamic acid because the interaction between mefenamic acid and Avicel PH-101 creates 
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